Published January 1, 2012 | Version v1
Journal article Open

Four novel and two recurrent NHLRC1 (EPM2B) and EPM2A gene mutations leading to Lafora disease in six Turkish families

  • 1. Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey
  • 2. Istanbul Univ, Cerrahpasa Med Sch, Dept Neurol, Istanbul, Turkey
  • 3. Ege Univ, Sch Med, Dept Neurol, Izmir, Turkey
  • 4. Karadeniz Tech Univ, Dept Neurol, Sch Med, Trabzon, Turkey

Description

Lafora disease (LD) is a type of autosomal recessive, progressive myoclonus epilepsy resulting mostly from mutations in the EPM2A and NHLRC1 genes. Mutational analysis in both genes was initiated with the aim of establishing LD DNA diagnosis in Turkey. Four novel NHLRC1 (p.G131X, p.P69S and p.D82H) and EPM2A (p.V7A) and two recurrent NHLRC1 (p.D146N) and EPM2A (p.R241X) mutations were identified in six families. The delineation of causative mutations in patients provided early disease diagnosis for other family members and contributed to the knowledge of LD pathogenesis. (C) 2011 Elsevier B.V. All rights reserved.

Files

bib-566b16bb-a71c-42f0-a135-224123db8a42.txt

Files (262 Bytes)

Name Size Download all
md5:135fc560df56b4a6325fd2df7357d850
262 Bytes Preview Download